Skip to content

Chemotherapy Source Book

Spend $50 to get a free DVD!

ISBN-10: 0683068687

ISBN-13: 9780683068689

Edition: 2nd 1996 (Revised)

Authors: Michael C. Perry

List price: $110.00
Blue ribbon 30 day, 100% satisfaction guarantee!
Out of stock
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!


The updated Third Edition of The Chemotherapy Source Book is the most current and comprehensive reference on cancer chemotherapy. It brings together pharmacologic and patient management information in one source that practitioners can consult for any question encountered in the delivery of chemotherapy. This edition features increased information on the expanding use of high-dose therapy for various cancers, including breast cancer, leukemias, multiple myeloma, Hodgkin's disease, non-Hodgkin's lymphoma, lung cancer, and ovarian cancer. Coverage also includes new material on monoclonal antibodies, monoclonal antibody therapy, and breast, colon, and lung cancers, and information on five new…    
Customers also bought

Book details

List price: $110.00
Edition: 2nd
Copyright year: 1996
Publisher: Lippincott Williams & Wilkins
Binding: Hardcover
Pages: 1184
Size: 7.00" wide x 10.25" long
Language: English

Contributing Authorsp. vii
Prefacep. xiii
Principles of Chemotherapy
Scientific Foundation of Chemotherapy
Scientific Basis of Cancer Chemotherapyp. 1
Antineoplastic Drug Developmentp. 6
Principles of Pharmacologyp. 14
Norton-Simon Hypothesisp. 23
Drug Resistancep. 37
Adjuvant Chemotherapyp. 48
Combination Chemotherapyp. 69
Combined Modality Therapyp. 73
Design and Interpretation of Clinical Trialsp. 81
Clinical Trialsp. 89
Hematopoietic Growth Factorsp. 94
Biologic Response Modifiers: Principles of Biotherapyp. 105
Circadian Timing of Cancer Chemotherapyp. 114
Routes of Administration
Intraventricular and Intrathecal Therapyp. 132
Intraperitoneal Chemotherapyp. 141
Continuous Intravenous Infusion Chemotherapyp. 144
Intraarterial Therapyp. 163
Perfusion Therapyp. 174
Hematopoietic Stem Cell Transplantationp. 185
Chemotherapeutic Drugs
Covalent DNA-Binding Drugsp. 192
Antimetabolitesp. 208
Antitumor Antibiotics and Related Compoundsp. 227
Microtubule-Targeting Drugsp. 252
DNA Topoisomerase II Inhibitorsp. 278
Topoisomerase I-Targeting Drugsp. 289
Differentiation Agentsp. 304
Hormonesp. 312
L-Asparaginasep. 323
Investigational Drugsp. 325
Antibodiesp. 394
Management of Drug Toxicity
Hematologic Complications of Cancer Chemotherapyp. 399
Oral Toxicityp. 406
Dermatologic Toxicityp. 424
Extravasationp. 432
Hypersensitivity Reactionsp. 436
Ocular Side Effects of Chemotherapyp. 452
Cardiotoxicity of Chemotherapeutic Drugsp. 458
Chemotherapy-Associated Lung Injuryp. 468
Gastrointestinal Complications of Chemotherapyp. 477
Hepatotoxicity of Chemotherapeutic Agentsp. 483
Renal and Electrolyte Abnormalities Due to Chemotherapyp. 494
Neurotoxicity of Chemotherapy Agentsp. 504
Vascular Toxicityp. 514
Second Malignancies after Chemotherapyp. 526
Chemotherapy in Pregnancyp. 537
Gonadal Complications and Teratogenicity of Cancer Therapyp. 546
Drug Administration
Central Venous Access for Chemotherapyp. 559
Risks of Handling Cytotoxic Drugsp. 566
Patient Educationp. 583
Current Therapy of Specific Solid Tumors
Chemotherapy of Melanomap. 596
Chemotherapy of Primary Brain Tumorsp. 602
Chemotherapy of Head and Neck Cancerp. 610
Chemotherapy of Lung Cancerp. 626
Chemotherapy of Breast Cancerp. 647
Chemotherapy of Gastrointestinal Cancerp. 689
Chemotherapy of Endocrine Tumorsp. 698
Chemotherapy of Genitourinary Cancersp. 710
Chemotherapy of Gynecologic Cancerp. 732
Chemotherapy of Sarcomas of Bone and Soft Tissuep. 760
Chemotherapy of Carcinoma of Unknown Primary Sitep. 778
Chemotherapy of Pediatric Solid Tumorsp. 788
Chemotherapy of Hematologic Malignancies
Chemotherapy of Hodgkin's Diseasep. 795
Chemotherapy of Non-Hodgkin's Lymphomap. 810
Chemotherapy of Acute Leukemia in Adultsp. 824
Chemotherapy and Immunotherapy of Chronic Lymphocytic Leukemia and Hairy Cell Leukemiap. 839
Chemotherapy of the Myelodysplastic Syndromesp. 849
Management of Chronic Myeloproliferative Disorders and Chronic Myelocytic Leukemiap. 857
Chemotherapy of Multiple Myeloma and Related Plasma Cell Dyscrasiasp. 865
Chemotherapy Programsp. 876
Common Toxicity Criteriap. 905
Indexp. 941
Table of Contents provided by Syndetics. All Rights Reserved.